Magnet for Talent

Cortex Innovation Community

C2N Diagnostics, LLC, is a privately held protein diagnostic and therapeutic discovery company targeting progressive neurodegeneration located in the Cortex. It was founded by David Holtzman, MD, Randall Bateman, MD, and LifeTech Research. MATT MILLER/WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
View Content

Washington University is both a founding benefactor and beneficiary of the Cortex Innovation Community, a bioscience and technology hub. Watch how Cortex is supporting an ecosystem of innovation and entrepreneurship and spurring new residential and retail development.